Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer

M El-Tanani, H Nsairat, AA Aljabali… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction The resistance to chemotherapy is a significant hurdle in breast cancer
treatment, prompting the exploration of innovative strategies. This review discusses the …

The role of the gut microbiome in gastrointestinal cancers

Y Mishra, A Ranjan, V Mishra, A Chattaraj… - Cellular …, 2023 - Elsevier
The gut microbiota present in the human digestive system is incredibly varied and is home to
trillions of microorganisms. The gut microbiome is shaped at birth, while numerous genetic …

Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer

M El-Tanani, A Platt-Higgins, H Nsairat, II Matalka… - Life sciences, 2023 - Elsevier
Purpose Existing prognostic biomarkers are inadequate for stratifying breast cancer patients
with the highest risk of tumor progression at the time of diagnosis. Here, we demonstrate that …

[HTML][HTML] Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation

A Almilaibary - Saudi Journal of Biological Sciences, 2024 - Elsevier
Cancer of the breast is the mainly prevalent class of cancer in females diagnosed over the
globe. It also happens to be the 2nd most prevalent reason of cancer-related deaths among …

[HTML][HTML] A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma

Z Zhang, C Zhao, S Yang, W Lu, J Shi - Lipids in Health and Disease, 2024 - Springer
Background The molecular diversity exhibited by diffuse large B-cell lymphoma (DLBCL) is
a significant obstacle facing current precision therapies. However, scoring using the …

In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system

B Abu-Hdaib, H Nsairat, M El-Tanani, I Al-Deeb… - …, 2024 - Taylor & Francis
Aim: To investigate the therapeutic potential of mebendazole (MBZ)-loaded nanostructured
lipid carriers (NLCs). Methodology: NLC-MBZ was prepared and characterized to evaluate …

Targeting guanine nucleotide exchange factors for novel cancer drug discovery

SF Bannoura, HY Khan, MH Uddin… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Guanine nucleotide exchange factors (GEFs) regulate the activation of small
GTPases (G proteins) of the Ras superfamily proteins controlling cellular functions. Ras …

[HTML][HTML] Secretome analysis of breast cancer cells to identify potential target proteins of Ipomoea turpethum extract-loaded nanoparticles in the tumor …

S Swami, M Mughees, IR Mangangcha… - Frontiers in Cell and …, 2023 - frontiersin.org
Background: Breast cancer is the leading cause of frequent malignancy and morbidity
among women across the globe, with an increment of 0.5% incidences every year. The …

[HTML][HTML] The nexus of nuclear envelope dynamics, circular economy and cancer cell pathophysiology

K Keuper, J Bartek, A Maya-Mendoza - European Journal of Cell Biology, 2024 - Elsevier
The nuclear envelope (NE) is a critical component in maintaining the function and structure
of the eukaryotic nucleus. The NE and lamina are disassembled during each cell cycle to …

[HTML][HTML] Fumarate Hydratase Enhances the Therapeutic Effect of PD-1 Antibody in Colorectal Cancer by Regulating PCSK9

L Qin, L Shi, Y Wang, H Yu, Z Du, M Chen, Y Cai… - Cancers, 2024 - mdpi.com
Simple Summary This research revealed that the downregulation of fumarate hydratase in
patients is associated with poor prognosis. Mechanistically, FH binds to RAN, which inhibits …